IKT icon

Inhibikase Therapeutics

24 hedge funds and large institutions have $2.78M invested in Inhibikase Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ACM
1
ACT Capital Management
Pennsylvania
$853K 937,500
Vanguard Group
2
Vanguard Group
Pennsylvania
$482K 530,098
Fidelity Investments
3
Fidelity Investments
Massachusetts
$394K 433,300
William Blair & Company
4
William Blair & Company
Illinois
$163K 179,000 +154,000 +616%
HLA
5
Hamilton Lane Advisors
Pennsylvania
$151K 165,635
Renaissance Technologies
6
Renaissance Technologies
New York
$113K 124,683 -97,217 -44%
RAM
7
Redmond Asset Management
Virginia
$111K 122,477 -205 -0.2%
ZCA
8
Zeke Capital Advisors
Pennsylvania
$85K 93,800
Geode Capital Management
9
Geode Capital Management
Massachusetts
$81K 89,226
Koshinski Asset Management
10
Koshinski Asset Management
Illinois
$59K 65,377
State Street
11
State Street
Massachusetts
$55K 60,500
RPCONE
12
Retirement Planning Company of New England
Rhode Island
$53K 59,069 -5,537 -9%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$36K 39,312
Northern Trust
14
Northern Trust
Illinois
$26K 28,872
Citadel Advisors
15
Citadel Advisors
Florida
$22K 24,114 +24,114 New
CWM
16
CCG Wealth Management
California
$18K 20,000 +20,000 New
KJHP
17
K.J. Harrison & Partners
Ontario, Canada
$17K 18,300
Millennium Management
18
Millennium Management
New York
$14K 15,934 +15,934 New
WAM
19
Warberg Asset Management
Illinois
$13K 14,493
SG
20
StoneX Group
New York
$12.1K 13,313 +13,313 New
Morgan Stanley
21
Morgan Stanley
New York
$9K 10,000
UBS Group
22
UBS Group
Switzerland
$7K 7,499 +7,499 New
TRCT
23
Tower Research Capital (TRC)
New York
$6K 6,166 -9,856 -62%
AC
24
Antara Capital
New York
-403,000 Closed
SC
25
Shay Capital
New York
-10,708 Closed